Adipose Tissue Blood Flow in Aging Humans
Launched by MAYO CLINIC · Oct 19, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Adipose Tissue Blood Flow in Aging Humans," is looking to understand how blood flow in fat tissue changes as people age. Researchers want to find out if there are differences in blood flow in this tissue between younger adults (ages 18-35) and older adults (ages 65-80). They will also investigate what biological changes might be happening in the body that relate to these differences in blood flow.
To be eligible for the trial, participants should be healthy adults between 18-35 years or 65-80 years old with a body mass index (BMI) between 20 and 25. Those with certain health conditions, like diabetes or heart problems, or who are pregnant, nursing, or smokers, cannot participate. If you choose to join the study, you will have some tests done to measure blood flow in your fat tissue and provide small samples of fat tissue for analysis. You will also drink a sugary drink as part of the study. This research aims to help us learn more about how aging affects fat tissue and overall health.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • Within the ages of 18-35 years or 65-80 years at time of study visit
- • BMI between 20-25.0 kg/m2.
- Exclusion criteria:
- • Presence of diagnosed cardiometabolic diseases (e.g., Type 2 diabetes, hypertension, Heart Failure)
- • Taking prescription anticoagulants
- • Taking prescriptions or supplements that effect adipose tissue metabolism (i.e., statins, Thiazolidinediones, niacin, atypical antipsychotics, or fish oil)
- • Pregnant or nursing
- • Inability to provide written informed consent
- • Smokers
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Kelli Lytle, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported